Literature DB >> 21422102

Cardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemia.

Zhi-Dong Ge1, Irina A Ionova, Nikolina Vladic, Danijel Pravdic, Naoyuki Hirata, Jeannette Vásquez-Vivar, Phillip F Pratt, David C Warltier, Galen M Pieper, Judy R Kersten.   

Abstract

AIMS: Hyperglycaemia (HG) decreases intracellular tetrahydrobiopterin (BH(4)) concentrations, and this action may contribute to injury during myocardial ischaemia and reperfusion. We investigated whether increased BH(4) by cardiomyocyte-specific overexpression of the GTP cyclohydrolase (GTPCH) 1 gene rescues myocardial and mitochondrial protection by ischaemic preconditioning (IPC) during HG through a nitric oxide (NO)-dependent pathway. METHODS AND
RESULTS: Mice underwent 30 min of myocardial ischaemia followed by 2 h of reperfusion with or without IPC elicited with four cycles of 5 min ischaemia/5 min of reperfusion in the presence or absence of HG produced by d-glucose. In C57BL/6 wild-type mice, IPC increased myocardial BH(4) and NO concentrations and decreased myocardial infarct size (30 ± 3% of risk area) compared with control (56 ± 5%) experiments. This protective effect was inhibited by HG (48 ± 3%) but not hyperosmolarity. GTPCH-1 overexpression increased myocardial BH(4) and NO concentrations and restored cardioprotection by IPC during HG (32 ± 4%). In contrast, a non-selective NO synthase inhibitor N(G)-nitro-l-arginine methyl ester attenuated the favourable effects of GTPCH-1 overexpression (52 ± 3%) during HG. Mitochondria isolated from myocardium subjected to IPC required significantly higher in vitro Ca(2+) concentrations (184 ± 14 µmol mg(-1) protein) to open the mitochondrial permeability transition pore when compared with mitochondria isolated from control experiments (142 ± 10 µmol mg(-1) protein). This beneficial effect of IPC was reversed by HG and rescued by GTPCH-1 overexpression.
CONCLUSION: Increased BH(4) by cardiomyocyte-specific overexpression of GTPCH-1 preserves the ability of IPC to elicit myocardial and mitochondrial protection that is impaired by HG, and this action appears to be dependent on NO.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422102      PMCID: PMC3125073          DOI: 10.1093/cvr/cvr079

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  48 in total

Review 1.  Oxygen reduction by nitric-oxide synthases.

Authors:  D Stuehr; S Pou; G M Rosen
Journal:  J Biol Chem       Date:  2001-03-09       Impact factor: 5.157

Review 2.  The late phase of preconditioning.

Authors:  R Bolli
Journal:  Circ Res       Date:  2000-11-24       Impact factor: 17.367

3.  Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels.

Authors:  J R Kersten; M W Montgomery; T Ghassemi; E R Gross; W G Toller; P S Pagel; D C Warltier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-04       Impact factor: 4.733

4.  Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta.

Authors:  Eric R Gross; Anna K Hsu; Garrett J Gross
Journal:  Diabetes       Date:  2007-01       Impact factor: 9.461

5.  Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart.

Authors:  F Di Lisa; R Menabò; M Canton; M Barile; P Bernardi
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.157

6.  Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus.

Authors:  T Heitzer; K Krohn; S Albers; T Meinertz
Journal:  Diabetologia       Date:  2000-11       Impact factor: 10.122

7.  Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning.

Authors:  A Nakano; G S Liu; G Heusch; J M Downey; M V Cohen
Journal:  J Mol Cell Cardiol       Date:  2000-07       Impact factor: 5.000

8.  Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse.

Authors:  Yiru Guo; Qianhong Li; Wen-Jian Wu; Wei Tan; Xiaoping Zhu; Jingyao Mu; Roberto Bolli
Journal:  J Mol Cell Cardiol       Date:  2008-01-17       Impact factor: 5.000

9.  Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation.

Authors:  Subodh Verma; Andrew Maitland; Richard D Weisel; Paul W M Fedak; Neil C Pomroy; Shu-Hong Li; Donald A G Mickle; Ren-Ke Li; Vivek Rao
Journal:  J Thorac Cardiovasc Surg       Date:  2002-06       Impact factor: 5.209

10.  Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4.

Authors:  Cristian Dumitrescu; Roberto Biondi; Yong Xia; Arturo J Cardounel; Lawrence J Druhan; Giuseppe Ambrosio; Jay L Zweier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

View more
  18 in total

1.  Effect of remote ischemic postconditioning during thrombolysis in STEMI.

Authors:  S Ghaffari; L Pourafkari; S Manzouri; N D Nader
Journal:  Herz       Date:  2017-03-17       Impact factor: 1.443

2.  Failure of Isoflurane Cardiac Preconditioning in Obese Type 2 Diabetic Mice Involves Aberrant Regulation of MicroRNA-21, Endothelial Nitric-oxide Synthase, and Mitochondrial Complex I.

Authors:  Zhi-Dong Ge; Yingchuan Li; Shigang Qiao; Xiaowen Bai; David C Warltier; Judy R Kersten; Zeljko J Bosnjak; Mingyu Liang
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

3.  Up-regulation of microRNA-21 mediates isoflurane-induced protection of cardiomyocytes.

Authors:  Jessica M Olson; Yasheng Yan; Xiaowen Bai; Zhi-Dong Ge; Mingyu Liang; Alison J Kriegel; Danielle M Twaroski; Zeljko J Bosnjak
Journal:  Anesthesiology       Date:  2015-04       Impact factor: 7.892

4.  Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning.

Authors:  Nikolina Vladic; Zhi-Dong Ge; Thorsten Leucker; Anna K Brzezinska; Jian-Hai Du; Yang Shi; David C Warltier; Phillip F Pratt; Judy R Kersten
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-09       Impact factor: 4.733

5.  Isoflurane favorably modulates guanosine triphosphate cyclohydrolase-1 and endothelial nitric oxide synthase during myocardial ischemia and reperfusion injury in rats.

Authors:  Ines Baotic; Dorothee Weihrauch; Jesse Procknow; Jeanette Vasquez-Vivar; Zhi-Dong Ge; Shaan Sudhakaran; David C Warltier; Judy R Kersten
Journal:  Anesthesiology       Date:  2015-09       Impact factor: 7.892

6.  MicroRNA-21 Mediates Isoflurane-induced Cardioprotection against Ischemia-Reperfusion Injury via Akt/Nitric Oxide Synthase/Mitochondrial Permeability Transition Pore Pathway.

Authors:  Shigang Qiao; Jessica M Olson; Mark Paterson; Yasheng Yan; Ivan Zaja; Yanan Liu; Matthias L Riess; Judy R Kersten; Mingyu Liang; David C Warltier; Zeljko J Bosnjak; Zhi-Dong Ge
Journal:  Anesthesiology       Date:  2015-10       Impact factor: 7.892

7.  Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.

Authors:  Shelley L Baumgardt; Mark Paterson; Thorsten M Leucker; Juan Fang; David X Zhang; Zeljko J Bosnjak; David C Warltier; Judy R Kersten; Zhi-Dong Ge
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

8.  Increasing tetrahydrobiopterin in cardiomyocytes adversely affects cardiac redox state and mitochondrial function independently of changes in NO production.

Authors:  Savitha Sethumadhavan; Jennifer Whitsett; Brian Bennett; Irina A Ionova; Galen M Pieper; Jeannette Vasquez-Vivar
Journal:  Free Radic Biol Med       Date:  2016-01-27       Impact factor: 7.376

9.  The protein partners of GTP cyclohydrolase I in rat organs.

Authors:  Jianhai Du; Ru-Jeng Teng; Matt Lawrence; Tongju Guan; Hao Xu; Ying Ge; Yang Shi
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

Review 10.  Tetrahydrobiopterin in cardiovascular health and disease.

Authors:  Jennifer K Bendall; Gillian Douglas; Eileen McNeill; Keith M Channon; Mark J Crabtree
Journal:  Antioxid Redox Signal       Date:  2014-03-14       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.